Acute hematological, metabolic, and inflammatory responses to simulated-6000 ft masked versus unmasked high-intensity interval training in youth soccer players: a randomized crossover pilot study Authors: Tevfik Akol, Ayşegül Yapici, Gülin Findikoğlu Ergin, Engin Güneş Atabaş Published: 2025 ABSTRACT BackgroundHigh-intensity interval training (HIIT) with respiratory-restricting masks is used to simulate hypoxic training and potentially enhance physiological adaptations. However, the acute hematological, metabolic, and inflammatory responses to masked versus unmasked HIIT in youth soccer players remain unclear. This study aimed to compare these responses during simulated 6000-ft masked and unmasked HIIT.MethodsTwelve male amateur soccer players completed two HIIT sessions in a randomized crossover design: one with a simulated 6000-ft training mask and one without. Each session consisted of identical high-intensity running intervals. Heart rate and oxygen saturation were monitored continuously. Blood samples were collected pre- and post-exercise to assess lactate, hemoglobin, hematocrit, platelet count, C-reactive protein, glucose, total cholesterol, free-fatty acids, insulin, cortisol, and creatine kinase. Paired statistical tests were used to compare pre- to post-exercise changes and between-condition differences.ResultsBoth masked and unmasked sessions increased heart rate and reduced oxygen saturation compared with baseline, with no significant between-condition differences (p > 0.20). Masked HIIT induced greater lactate accumulation (5.11 ± 1.59 vs. 4.34 ± 1.32 mmol·L⁻¹; p = 0.015) and larger increases in hemoglobin (p = 0.006), hematocrit (p = 0.013), and platelet count (p = 0.015), indicating enhanced hemoconcentration. C-reactive protein rose only after masked exercise, though the between-condition difference was non-significant (p = 0.513). Post-exercise glucose was higher in the masked condition, whereas unmasked HIIT elicited larger increases in total cholesterol (p = 0.002) and free-fatty acids. Insulin decreased similarly after both protocols (p < 0.05), and cortisol and creatine kinase remained unchanged (p > 0.05).ConclusionsThe simulated 6000-ft training mask augmented metabolic acidosis, hemoconcentration, and acute inflammatory stress without additional cardiovascular or arterial oxygen desaturation compared to unmasked HIIT. These findings suggest that such masks may provide a manageable yet heightened physiological stimulus, potentially useful for targeted training adaptations, provided hydration and recovery are carefully monitored. Introduction Exercise imposes a purposeful physiological stress that drives multi-system adaptations; optimising these adaptations within tight preparatory windows while limiting monotony-induced plateaus has therefore become a central concern for sport scientists and strength-and-conditioning coaches [1, 2]. Soccer is an intermittent high-intensity sport that blends explosive actions with prolonged aerobic activity. Elite matches typically involve ≈ 1 200–1 400 rapid sprints, jumps, tackles, decelerations and direction changes every 2–4 s, taxing both glycolytic and oxidative pathways [3–5]. Meeting these demands requires large aerobic reserves; however, traditional volume-oriented endurance blocks are time-consuming and may clash with congested competition schedules. High-intensity interval training (HIIT) offers a practical alternative. The American College of Sports Medicine (ACSM) recommends work bouts at ≥ 80% HRₘₐₓ lasting 30 s–2 min, interspersed with active recovery until HR falls to 40–50% HRₘₐₓ, for three-to-five cycles, three-to-seven times per week [6]. Soccer-specific HIIT formats—such as supramaximal Eurofit runs and maximal-aerobic-speed sessions—produce rapid gains in VO₂max and match-running capacity [7, 8] while helping coaches balance load and recovery. Among the many HIIT variants, early protocols (e.g. the Wingate all-out cycling test) and subsequent whole-body functional workouts—Tabata, Gibala, Timmons, circuit-based resistance, the Insanity programme and the Supramaximal Eurofit method—illustrate the field’s pursuit of time-efficient stimuli. Although popular, empirical support for several of these formats remains limited, warranting further research across athletic populations. Altitude-based strategies can magnify training stress via haematological and ventilatory adaptations. Live-high/train-low camps stimulate erythropoiesis but entail logistical challenges, prompting interest in altitude-simulating “training masks”—adjustable-valve devices that restrict airflow and mimic ≈ 900–5 500 m elevations by increasing diaphragmatic work [9, 10]. Chronic mask use has improved forced vital capacity and ventilatory threshold [11], yet other trials report negligible performance gains [12]. Acute evidence is equally mixed. Some studies demonstrate greater lactate accumulation, haemoconcentration and inflammatory responses with masks [13, 14], whereas others find only minor perturbations. Consequently, whether the transient stress imposed by respiratory restriction translates into meaningful adaptations for field-sport athletes remains unresolved. The present study therefore compared the acute metabolic, hormonal and haematological effects of a supramaximal Eurofit-HIIT bout performed with a simulated-6 000 ft training mask versus an identical unmasked bout in amateur soccer players. We hypothesised that the masked session would elicit higher post-exercise lactate, greater haemoconcentration (haemoglobin, haematocrit, platelet count) and stronger inflammatory responses (C-reactive protein), alongside distinct metabolic-hormonal shifts in glucose, insulin and cortisol relative to the unmasked condition. Clarifying these responses will guide practitioners in deciding whether respiratory-restricting masks provide a worthwhile stimulus—or merely add recoverable strain—when designing time-efficient conditioning programmes for soccer players. Methods Participants Twelve healthy male amateur soccer players (age = 20.3 ± 1.4 y, height = 178.4 ± 5.9 cm, mass = 72.1 ± 6.8 kg, VO₂max = 56.1 ± 4.3 mL•kg⁻¹•min⁻¹, training age = 9 ± 2 y, weekly training = 6.5 ± 1.2 h) volunteered between September and November 2022. Players represented various field positions (defenders, midfielders, forwards) to reflect the physiological variability within match demands. Inclusion criteria were: non-smoker, BMI < 30 kg•m⁻², no cardiovascular or metabolic disease, no medication use, free of infection, and no exposure to high-altitude or mask-based training in the preceding 3 months. An a priori power analysis (G*Power 3.1; two-tailed paired t test, effect size 0.5 based on previous literature, α = 0.05, power = 0.80) confirmed that n = 12 was sufficient. The random allocation sequence was computer-generated with 1:1 assignment to MASK–CTRL or CTRL–MASK sequences. Randomisation was prepared by an investigator not involved in data collection; participant assignment was conducted by a blinded assistant. All participants and guardians provided written informed consent. The protocol conformed to the Declaration of Helsinki and was approved by the Pamukkale University Non-Interventional Clinical Research Ethics Committee (60116787-020/71453). Procedures The study followed a prospective, randomised, single-blind, two-period crossover design. Block randomisation (block = 4) determined whether each player completed the masked (MASK) or unmasked control (CTRL) session first; trials were separated by a 7-day wash-out. Testing was performed indoors (22 ± 1 °C; 45 ± 5% relative humidity) between 07:30 and 09:30 h. Participants abstained from strenuous exercise for 24 h and caffeine/alcohol for 12 h, arrived euhydrated (urine specific gravity ≤ 1.020), and were instructed to consume their last meal ≥ 3 h before testing. In the MASK session, athletes wore a TrainingMask 3.0 (TrainingMask LLC, USA) set to resistance level 6 (manufacturer-verified ≈ 6 000 ft/1 829 m). Resistance level was verified using a calibrated digital manometer to confirm the manufacturer’s pressure-flow curve. Fit was confirmed with a negative-pressure check and the mask remained in place throughout exercise. After 5 min seated rest, baseline heart-rate (HR) and arterial oxygen saturation (SpO₂) were recorded with a finger pulse-oximeter (Contec CMS50D+, accuracy ± 2 bpm/± 2%), and an 8-mL venous sample was drawn from the antecubital vein. Determination of maximal aerobic speed (MAS) The maximal aerobic speed (MAS) of each participant was determined using the 20-m multistage shuttle run test (Léger protocol). The final running speed achieved during the test was recorded, and MAS was defined as the terminal velocity (km·h⁻¹). Exercise intensities during all HIIT sessions were individualized and set at 100% of each participant’s MAS to ensure comparable relative workloads. Eurofit protocol (Fig. 1) Each player’s individual maximal-aerobic-speed (MAS) was first determined and the target distance set at 120% MAS. Athletes lined up on the start line and, on the whistle, ran to their personal marker cone in exactly 15 s, rested there for 15 s, and then ran back to the start line in the next 15 s. This 15 s out/15 s rest/15 s return cycle was performed continuously for an initial 5-min bout and was subsequently progressed to 8–10 min. A session comprised one to two sets separated by 3 min passive recovery; sets were only initiated when HR had dropped to ≤ 60% HRmax to standardise recovery status. After 3–4 weeks of familiarisation, external load could be increased to 125–130% MAS by relocating the cones accordingly. For the present trial, the protocol was implemented as two 8-min sets (total session ≈ 22 min). Verbal encouragement was standardised and delivered by the same investigator using pre-defined motivational phrases to ensure consistency. Post-exercise HR and SpO₂ were recorded within 2 min, a second venous sample was collected, and capillary blood lactate was obtained 3 min later using a handheld analyser (Lactate Scout +, EKF Diagnostics).Fig. 1Eurofit method Eurofit method Recovery and set standardization Each participant performed one set of HIIT per experimental condition. A second set was completed only if the participant’s heart-rate recovery criterion (≤ 60% HR_max within 3 min) was not reached after the first set. This approach ensured comparable recovery status and physiological readiness before post-exercise blood sampling. Heart-rate responses were continuously monitored using a Polar H10 chest-strap sensor (Polar Electro, Finland). During passive recovery periods, participants remained seated on a bench, refraining from movement or conversation. Recovery intervals ended once HR declined to ≤ 60% HR_max, at which point the next bout commenced. Total session duration was recorded for each condition and later added to Table 2. Monitoring of cycle duration Heart-rate data were continuously recorded, and the transition to the next exercise bout occurred once HR declined to ≤ 60% HRmax. The total session duration was also documented for each participant. Sessions performed with the mask tended to last slightly longer (mean ± SD = 14.8 ± 1.6 min) compared with the unmasked condition (13.4 ± 1.3 min), reflecting the slower HR recovery associated with restricted breathing. Definition of passive recovery During the passive recovery period, participants remained seated on a bench, refraining from any movement or conversation. This seated position was standardized across all sessions and participants to minimize variability in chronotropic recovery. Measurements Anthropometry Standing stature was measured to the nearest 0.1 cm with a portable stadiometer (SECA 213, Hamburg, Germany; technical accuracy ± 1 mm). Body mass and whole-body fat percentage were obtained with a multi-frequency segmental analyser (Tanita BC-418 MA, Tokyo, Japan; scale precision ± 0.1 kg) after participants had refrained from food and fluid intake for ≥ 2 h. Measurements were taken in duplicate and the mean value was used for analysis. Physiological indices: Resting HR and SpO₂ were recorded after 5 min seated rest; the same measurements were repeated within 2 min of exercise cessation. A finger-tip pulse-oximeter (Contec CMS50D +, Qinhuangdao, China) with stated accuracy of ± 2 beats•min⁻¹ for HR and ± 2% for SpO₂ was used. Capillary blood lactate was assessed 3 min post-exercise via the earlobe, preceded by gentle rubbing to induce hyperaemia, using a hand-held analyser (Lactate Scout +, EKF Diagnostics, Leipzig, Germany; coefficient of variation < 3%). The analyser was calibrated each test day with manufacturer-supplied control solutions. Haematology: Venous samples (EDTA, 3 mL) were drawn from the antecubital vein immediately (< 2 min) before and after the HIIT protocol while participants were seated to avoid postural shifts in plasma volume. A fully automated haematology system (Sysmex XN-1000, Kobe, Japan; analytic CV < 2%) provided total leukocyte count (WBC), neutrophil count and percentage, platelet count (PLT), haemoglobin (Hb) and haematocrit (Hct). The analyser’s internal quality-control function verified calibration twice daily, and the laboratory participated in an external QC programme to ensure inter-lab comparability. Biochemistry: Serum tubes (5 mL, clot activator) were centrifuged at 3 000 g for 10 min at 4 °C; aliquots were analysed within 30 min on a modular chemistry platform (Roche Cobas 8000, Basel, Switzerland; analytic CV < 3%). Assays included fasting-sensitive metabolic markers (glucose, insulin), stress-hormone cortisol, muscle-damage index creatine kinase (CK), inflammatory marker C-reactive protein (CRP), lipid profile (triglycerides, total-, LDL- and HDL-cholesterol) and free-fatty acids. All reagents and calibrators were lot-controlled, and two-level quality-control sera confirmed assay stability (acceptable range ± 2 SD). Duplicate measurements were taken for all primary variables; if coefficients of variation exceeded 5%, a third measurement was performed and the median value recorded. Laboratory analyses and reliability All analysers were calibrated daily. Duplicate quality-control samples yielded intra-assay CVs < 3% for primary outcomes. Test-retest reliability of the lactate device in-house (n = 10) showed ICC = 0.95. All 12 participants completed both masked (MASK) and unmasked (CTRL) sessions without any dropouts or missing data. Sample size determination and study design Sample size was determined a priori using G*Power 3.1 (Heinrich Heine University, Düsseldorf, Germany) for a two-tailed paired t test with an expected effect size of 0.50, α = 0.05, and statistical power (1 − β) = 0.80. This calculation indicated that 12 participants would be sufficient to detect a moderate within-subject effect. Considering that the 2 × 2 crossover design reduces between-subject variability and increases statistical efficiency, this sample size was deemed appropriate. Therefore, the present research was conducted as a pilot, exploratory study aimed at identifying physiological response patterns under masked versus unmasked high-intensity interval training conditions. Statistical analysis Data normality (Shapiro–Wilk), homogeneity of variance (Levene’s test), and sphericity (Mauchly) were verified. Primary outcomes were examined using a 2 (condition: MASK vs. CTRL) × 2 (time: Pre vs. Post) mixed ANOVA with Greenhouse–Geisser correction; Bonferroni tests followed significant interactions. Effect sizes were reported for all statistical comparisons. For within-condition Pre–Post changes, paired Cohen’s dz values were calculated and bias-corrected as Hedges gz. For between-condition paired contrasts at Post (MASK vs. CTRL), paired Hedges g values were computed. For the Condition × Time interaction, partial eta-squared (η²p) was extracted from the GLM output. For non-normally distributed data, r = Z/√N was used. All effect sizes are presented with 95% confidence intervals, with magnitudes interpreted as small (0.20/0.01), medium (0.50/0.06), and large (0.80/0.14) for dz/g and η²p, respectively. Significance was set at p < 0.05. All analyses were conducted using SPSS v29 (IBM Corp., Armonk, NY, USA). Results Participant characteristics Descriptive data are presented in Table 1. Participants were homogeneous at baseline with a mean age of 27.33 ± 4.88 y, stature 179.65 ± 6.66 cm, body mass 77.25 ± 8.05 kg, BMI 23.98 ± 1.30 kg m⁻², and 15.16 ± 3.86 y of training experience. No between-condition differences were evident prior to randomisation.Table 1Participant characteristics of the study sample (n = 12)VariableMean ± SDAge (years)27.33 ± 4.88Height (cm)179.65 ± 6.66Mass (kg)77.25 ± 8.05Training age (years)15.16 ± 3.86BMI (kg/m2)23.98 ± 1.30Data are mean ± SDBMI Body Mass Index Table 1Participant characteristics of the study sample (n = 12)VariableMean ± SDAge (years)27.33 ± 4.88Height (cm)179.65 ± 6.66Mass (kg)77.25 ± 8.05Training age (years)15.16 ± 3.86BMI (kg/m2)23.98 ± 1.30Data are mean ± SDBMI Body Mass Index Participant characteristics of the study sample (n = 12) Data are mean ± SD BMI Body Mass Index Cardiorespiratory responses A significant main effect of time was detected for heart rate (HR) and arterial oxygen saturation (SpO₂) (p < 0.001), whereas the condition × time interaction was non-significant (HR p = 0.253, η²p = 0.08; SpO₂ p = 0.206, η²p = 0.06), indicating small-to-moderate interaction effects. Both MASK and CTRL sessions elevated HR and reduced SpO₂ versus pre-exercise (Table 2). Capillary lactate exhibited a significant condition × time interaction (p = 0.015), with post-exercise values higher under MASK (5.11 ± 1.59 mmol·L⁻¹) than CTRL (4.34 ± 1.32 mmol·L⁻¹), corresponding to a moderate paired effect size (Hedges g = 0.51, 95% CI [0.09–0.92]). Recovery duration per set was significantly longer in MASK (14.8 ± 1.6 min) compared with CTRL (13.4 ± 1.3 min; p = 0.04, Hedges g = 0.46), indicating a moderate difference that reflected delayed heart-rate recovery under inspiratory resistance. This extended recovery may have contributed to the greater subsequent hematological and metabolic responses observed in MASK.Table 2Cardiorespiratory responses (heart rate, oxygen saturation, lactate, and recovery duration) during masked (MASK) and unmasked (CTRL) HIITVariableMASK PreMASK PostCTRL PreCTRL PostpEffect size (dz/g, 95% CI)HR (bpm)77.58 ± 12.32148.42 ± 32.55#78.36 ± 13.68134.08 ± 22.91#0.253η²p = 0.08 (small–moderate)SpO₂ (%)97.75 ± 1.2293.67 ± 2.15#98.17 ± 0.9495.08 ± 2.47#0.206η²p = 0.06 (small)Lactate (mmol L⁻¹)-5.11 ± 1.59*-4.34 ± 1.320.015g = 0.51 [0.09–0.92] (moderate)Recovery duration per set (min)-14.8 ± 1.6-13.4 ± 1.30.04g = 0.46 [0.05–0.86] (moderate)Data are mean ± SDHR heart rate, SpO₂ oxygen saturation, Lac blood lactate# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05) Table 2Cardiorespiratory responses (heart rate, oxygen saturation, lactate, and recovery duration) during masked (MASK) and unmasked (CTRL) HIITVariableMASK PreMASK PostCTRL PreCTRL PostpEffect size (dz/g, 95% CI)HR (bpm)77.58 ± 12.32148.42 ± 32.55#78.36 ± 13.68134.08 ± 22.91#0.253η²p = 0.08 (small–moderate)SpO₂ (%)97.75 ± 1.2293.67 ± 2.15#98.17 ± 0.9495.08 ± 2.47#0.206η²p = 0.06 (small)Lactate (mmol L⁻¹)-5.11 ± 1.59*-4.34 ± 1.320.015g = 0.51 [0.09–0.92] (moderate)Recovery duration per set (min)-14.8 ± 1.6-13.4 ± 1.30.04g = 0.46 [0.05–0.86] (moderate)Data are mean ± SDHR heart rate, SpO₂ oxygen saturation, Lac blood lactate# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05) Cardiorespiratory responses (heart rate, oxygen saturation, lactate, and recovery duration) during masked (MASK) and unmasked (CTRL) HIIT Data are mean ± SD HR heart rate, SpO₂ oxygen saturation, Lac blood lactate # = pre- vs. post-exercise difference within condition (p < 0.05) * = between-condition difference (p < 0.05) Haematological and inflammatory markers Total leukocyte (WBC) and neutrophil counts rose significantly after exercise in both conditions (time effect p < 0.001, dz = 0.60–0.68), without a condition interaction (WBC p = 0.073; NE p = 0.524). Haemoglobin, haematocrit, and platelet counts showed significant condition × time interactions—MASK elicited larger post-exercise increases than CTRL (Hb p = 0.006, Hedges g = 0.59; Hct p = 0.013, g = 0.55; PLT p = 0.015, g = 0.47), all indicating moderate effect magnitudes. Neutrophil percentage decreased only under MASK (p = 0.050, dz = 0.42). C-reactive protein (CRP) increased within MASK (p < 0.05, dz = 0.35) but the between-condition difference remained non-significant (p = 0.513). The absolute change (0.22–0.23 mg·L⁻¹) was trivial and within the expected analytical variability of the assay (Fig. 2, Table 3).Fig. 2Haematological markers before and after HIIT in MASK and CTRL conditions Haematological markers before and after HIIT in MASK and CTRL conditions Table 3Hematological and inflammatory indices before and after HIIT under masked (MASK) and control (CTRL) conditionsVariableMASK PreMASK PostCTRL PreCTRL Post p Effect size (dz/g, 95% CI)WBC (10³ µL⁻¹)6.75 ± 1.1211.10 ± 2.31#6.80 ± 1.239.82 ± 2.18#0.073dz = 0.60 [0.20–0.95] (moderate)NE (10³ µL⁻¹)3.66 ± 1.044.99 ± 1.37#3.69 ± 1.054.77 ± 1.31#0.524dz = 0.55 (moderate)NE (%)53.81 ± 8.9745.24 ± 8.96#*54.26 ± 8.6949.04 ± 8.65#0.050g = 0.42 (small–moderate)Hb (g dL⁻¹)16.07 ± 0.3516.55 ± 1.29#*15.71 ± 0.3316.04 ± 1.19#0.006g = 0.59 [0.18–0.97] (moderate)Hct (%)47.43 ± 0.4950.62 ± 3.78#*45.83 ± 0.9847.50 ± 3.83#0.013g = 0.55 [0.15–0.92] (moderate)PLT (10³ µL⁻¹)242 ± 38317 ± 52#*239 ± 32296 ± 44#0.015g = 0.47 [0.10–0.84] (moderate)CRP (mg dL⁻¹)0.22 ± 0.200.23 ± 0.21#0.18 ± 0.100.19 ± 0.100.513dz = 0.35 (small)Data are mean ± SDHb hemoglobin, Hct hematocrit, WBC white blood cells, NE neutrophils, PLT platelet count, CRP C-reactive protein# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05) Table 3Hematological and inflammatory indices before and after HIIT under masked (MASK) and control (CTRL) conditionsVariableMASK PreMASK PostCTRL PreCTRL Post p Effect size (dz/g, 95% CI)WBC (10³ µL⁻¹)6.75 ± 1.1211.10 ± 2.31#6.80 ± 1.239.82 ± 2.18#0.073dz = 0.60 [0.20–0.95] (moderate)NE (10³ µL⁻¹)3.66 ± 1.044.99 ± 1.37#3.69 ± 1.054.77 ± 1.31#0.524dz = 0.55 (moderate)NE (%)53.81 ± 8.9745.24 ± 8.96#*54.26 ± 8.6949.04 ± 8.65#0.050g = 0.42 (small–moderate)Hb (g dL⁻¹)16.07 ± 0.3516.55 ± 1.29#*15.71 ± 0.3316.04 ± 1.19#0.006g = 0.59 [0.18–0.97] (moderate)Hct (%)47.43 ± 0.4950.62 ± 3.78#*45.83 ± 0.9847.50 ± 3.83#0.013g = 0.55 [0.15–0.92] (moderate)PLT (10³ µL⁻¹)242 ± 38317 ± 52#*239 ± 32296 ± 44#0.015g = 0.47 [0.10–0.84] (moderate)CRP (mg dL⁻¹)0.22 ± 0.200.23 ± 0.21#0.18 ± 0.100.19 ± 0.100.513dz = 0.35 (small)Data are mean ± SDHb hemoglobin, Hct hematocrit, WBC white blood cells, NE neutrophils, PLT platelet count, CRP C-reactive protein# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05) Hematological and inflammatory indices before and after HIIT under masked (MASK) and control (CTRL) conditions Data are mean ± SD Hb hemoglobin, Hct hematocrit, WBC white blood cells, NE neutrophils, PLT platelet count, CRP C-reactive protein # = pre- vs. post-exercise difference within condition (p < 0.05) * = between-condition difference (p < 0.05) Metabolic-hormonal profile A significant condition × time interaction was observed for plasma glucose (p = 0.013, η²p = 0.12) and total cholesterol (p = 0.002, η²p = 0.18). Post-exercise glucose was higher in MASK (90.75 ± 27.68 mg·dL⁻¹) compared with CTRL (72.75 ± 13.51 mg·dL⁻¹), representing a moderate within-condition effect (Hedges gz = 0.47, 95% CI [0.05–0.88]). Total cholesterol increased in both conditions, with a large between-condition difference favouring MASK (p = 0.002, Hedges g = 0.81). Free fatty acids (FFA) showed no significant condition × time interaction (p = 0.129, η²p = 0.04 Insulin concentrations declined similarly in both sessions (p < 0.05, dz = 0.52), indicating a moderate within-condition effect. Cortisol and creatine kinase (CK) did not change significantly with time or condition (p >0.05, η²p < 0.03) [15]. Complete data for these metabolic and hormonal responses are reported in Table 4 and depicted graphically in Fig. 3.Table 4Metabolic and hormonal responses before and after masked (MASK) and control (CTRL) HIIT sessionsVariableMASK PreMASK PostCTRL PreCTRL PostpEffect size (dz/g, 95% CI)Glucose70.67 ± 11.0790.75 ± 27.68*67.17 ± 13.6872.75 ± 13.510.013gz = 0.47 [0.05–0.88] (moderate)Triglycerides119.92 ± 79.87135.50 ± 87.01#126.58 ± 77.01148.50 ± 91.14#0.254dz = 0.30 (small)Total cholesterol153.5 ± 31.78164.7 ± 30.35#*165.9 ± 31.28174.1 ± 32.75#0.002g = 0.81 [0.39–1.21] (large)LDL78.63 ± 32.2084.86 ± 28.9283.87 ± 27.6486.25 ± 24.500.093g = 0.20 (small)HDL50.00 ± 12.5154.00 ± 13.82#52.09 ± 13.7355.63 ± 14.74#0.184dz = 0.25 (small)VLDL24.08 ± 16.0627.00 ± 17.45#25.42 ± 15.4129.67 ± 18.14#0.236dz = 0.28 (small)FFA2149 ± 23891281 ± 14361403 ± 12912513 ± 14990.129η²p = 0.04 (small)CK248.67 ± 157.43278.83 ± 190.03#328.00 ± 270.35357.17 ± 305.000.413η²p = 0.02 (trivial)Cortisol12.94 ± 3.4514.47 ± 3.7412.78 ± 3.7913.14 ± 3.550.187η²p = 0.03 (small)Insulin16.81 ± 11.0310.50 ± 6.79#19.83 ± 12.7310.30 ± 7.94#1.000dz = 0.52 [0.10–0.90] (moderate)Data are mean ± SDGlucose, triglycerides, total-cholesterol, LDL, HDL, VLDL = mg dL⁻¹; FFA = nmol mL⁻¹; CK = U L⁻¹; cortisol = µg dL⁻¹; insulin = mU L⁻¹# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05)Fig. 3Changes in metabolic and hormonal markers before and after HIIT under masked and control conditions Table 4Metabolic and hormonal responses before and after masked (MASK) and control (CTRL) HIIT sessionsVariableMASK PreMASK PostCTRL PreCTRL PostpEffect size (dz/g, 95% CI)Glucose70.67 ± 11.0790.75 ± 27.68*67.17 ± 13.6872.75 ± 13.510.013gz = 0.47 [0.05–0.88] (moderate)Triglycerides119.92 ± 79.87135.50 ± 87.01#126.58 ± 77.01148.50 ± 91.14#0.254dz = 0.30 (small)Total cholesterol153.5 ± 31.78164.7 ± 30.35#*165.9 ± 31.28174.1 ± 32.75#0.002g = 0.81 [0.39–1.21] (large)LDL78.63 ± 32.2084.86 ± 28.9283.87 ± 27.6486.25 ± 24.500.093g = 0.20 (small)HDL50.00 ± 12.5154.00 ± 13.82#52.09 ± 13.7355.63 ± 14.74#0.184dz = 0.25 (small)VLDL24.08 ± 16.0627.00 ± 17.45#25.42 ± 15.4129.67 ± 18.14#0.236dz = 0.28 (small)FFA2149 ± 23891281 ± 14361403 ± 12912513 ± 14990.129η²p = 0.04 (small)CK248.67 ± 157.43278.83 ± 190.03#328.00 ± 270.35357.17 ± 305.000.413η²p = 0.02 (trivial)Cortisol12.94 ± 3.4514.47 ± 3.7412.78 ± 3.7913.14 ± 3.550.187η²p = 0.03 (small)Insulin16.81 ± 11.0310.50 ± 6.79#19.83 ± 12.7310.30 ± 7.94#1.000dz = 0.52 [0.10–0.90] (moderate)Data are mean ± SDGlucose, triglycerides, total-cholesterol, LDL, HDL, VLDL = mg dL⁻¹; FFA = nmol mL⁻¹; CK = U L⁻¹; cortisol = µg dL⁻¹; insulin = mU L⁻¹# = pre- vs. post-exercise difference within condition (p < 0.05)* = between-condition difference (p < 0.05) Metabolic and hormonal responses before and after masked (MASK) and control (CTRL) HIIT sessions Data are mean ± SD Glucose, triglycerides, total-cholesterol, LDL, HDL, VLDL = mg dL⁻¹; FFA = nmol mL⁻¹; CK = U L⁻¹; cortisol = µg dL⁻¹; insulin = mU L⁻¹ # = pre- vs. post-exercise difference within condition (p < 0.05) * = between-condition difference (p < 0.05) Changes in metabolic and hormonal markers before and after HIIT under masked and control conditions Collectively, MASK intensified lactate accumulation and haematological concentration while CTRL favoured greater lipid mobilisation, with comparable cardiac and oxygen-saturation stress in both modalities. The pattern of responses, supported by small-to-moderate effect sizes, highlights the physiological relevance of inspiratory resistance during intermittent high-intensity exercise. No adverse events, discomfort, or respiratory distress were observed during or after testing. No adverse events, discomfort, or respiratory distress were observed during or after testing. Discussion The present crossover trial compared the acute cardiorespiratory, haematological and metabolic responses to supramaximal Eurofit HIIT performed with (MASK) and without (CTRL) a simulated-altitude training mask. Three principal observations emerged: (i) MASK elicited significantly greater lactate accumulation but produced heart-rate and SpO₂ responses comparable to CTRL; (ii) MASK accentuated haemoconcentration (↑ Hb, Hct, PLT) and a transient neutrophil percentage drop, while overall leukocyte mobilisation was similar between conditions; and (iii) MASK elevated post-exercise glucose, whereas CTRL produced larger rises in total cholesterol and free-fatty acids. Collectively, these data indicate that adding inspiratory resistance augments metabolic-acid–base and haematological stress without additional cardiovascular load. Cardiorespiratory responses Both conditions elevated HR (~ 75 → 140–150 bpm) and reduced SpO₂ (~ 98 → 94–95%), confirming the high internal load of the 15 s/15 s shuttle format. Although MASK tended to depress SpO₂ further (93.7 ± 2.1%), the between-condition difference did not reach significance. Similar magnitudes have been reported during masked treadmill running [14, 16], yet others argue that commercial masks cannot reproduce the arterial desaturation of genuine hypoxia [5, 17]. Recent work has indicated that inspiratory resistance induces respiratory muscle overload rather than true hypoxic stress, which may explain the lack of significant SpO₂ divergence in the present study [18, 19]. Heart-rate difference and effect size Although the between-condition difference in mean heart rate (~ 14 bpm) did not reach statistical significance, the calculated effect size was moderate (Hedges g ≈ 0.58). This suggests a potentially meaningful physiological difference, with the MASK condition eliciting a greater chronotropic load despite similar external workloads. Such findings warrant further investigation in studies with larger samples. Lactate and metabolic load Higher post-exercise lactate with MASK (5.11 vs. 4.34 mmol·L⁻¹) supports the notion that restricted airflow shifts substrate utilisation towards anaerobic glycolysis [20]. Elevated glycolytic flux under simulated hypoxia aligns with work showing faster fatigue and greater perceived exertion in masked cycling [16] and confirms that the 120% MAS stimulus exceeded the athletes’ lactate steady-state intensity. Notably, chronic inspiratory muscle training (IMT) programmes have been shown to reduce exercise-induced lactate accumulation and improve endurance tolerance, suggesting that repeated MASK exposure might shift the metabolic profile over time [19]. Haematological adaptations Exercise-induced leukocytosis and neutrophilia occurred in both conditions, consistent with mobilisation from spleen and peripheral reservoirs [21]. The larger Hb, Hct and PLT increases under MASK likely reflect greater plasma-volume loss via respiratory water loss and sweating, i.e., haemoconcentration. Comparable findings have been reported after whole-body functional workouts with masks [13]. Recent studies confirm that inspiratory-resistance protocols can enhance erythrocyte mobilisation and platelet count acutely, but also highlight the need for monitoring to prevent excessive haemoconcentration in repeated exposures [19]. Biochemical profile MASK elevated glucose relative to CTRL, plausibly via catecholamine-mediated hepatic output under ventilatory stress [22]. Conversely, CTRL evoked greater lipolysis (↑ FFA, total-cholesterol), echoing data that unrestricted ventilation favours fat oxidation during HIIT [23]. Insulin declined similarly in both trials, indicating improved acute insulin sensitivity, while cortisol and CK remained stable, suggesting negligible muscle damage and systemic stress within a single bout [24]. Emerging evidence and mechanistic insights New evidence from 2023 to 2025 strengthens the mechanistic rationale: IMT combined with HIIT has been shown to improve inspiratory muscle strength, attenuate lactate build-up, and prolong time-to-exhaustion without altering VO₂max [19]. Inspiratory muscle warm-ups have been demonstrated to lower post-sprint lactate and peak HR in trained sprinters [25] Such findings reinforce that targeted respiratory muscle loading—whether through chronic IMT or acute MASK use—can meaningfully alter metabolic and ventilatory dynamics in high-intensity efforts. Conclusions Wearing a simulated-6000 ft inspiratory-resistance mask during supramaximal Eurofit HIIT markedly intensified the acute metabolic and haematological load—evidenced by larger lactate accumulation, transient haemoconcentration (↑ Hb, Hct, PLT) and a modest rise in C-reactive protein—without producing additional cardiovascular strain (HR, SpO₂ unchanged). Substrate use also diverged: masked exercise elevated post-exercise glucose, whereas unmasked exercise favoured lipid mobilisation. These findings position training masks as a targeted stimulus that can (i) challenge glycolytic pathways, (ii) provoke fluid-shift–driven erythrocyte mobilisation and (iii) provide a mild “live-low/train-high” analogue when true altitude exposure is impractical. Coaches may exploit these properties sparingly—particularly in pre-season blocks where aerobic gains have plateaued—by starting with ≤ 5-min sets, enforcing strict hydration, and monitoring HR and SpO₂ until athletes adapt. Practical applications Training masks can be used as a targeted stimulus when aerobic gains plateau, particularly in early pre-season blocks. Begin with a single 5-min set of 15 s out/15 s rest/15 s return at 120% MAS and progress to two 8- to 10-min sets only after two to three weeks of familiarisation. During each bout, monitor heart rate (aim ≤ 95% HR_max), arterial oxygen saturation (terminate or decrease resistance if SpO₂ falls below 90%), and perceived exertion (RPE ≤ 8/10). Athletes should lose no more than 2% body mass; therefore, enforce pre-/post-session hydration (≈ 6–8 mL·kg⁻¹ isotonic fluid). Because the mask acutely elevates lactate and concentrates haemoglobin, it is most useful for enhancing glycolytic tolerance and providing a mild “live-low/train-high” effect—yet it should be avoided in the final 72 h before competition and in athletes with respiratory or thrombotic contraindications. Pair masked sessions with robust recovery strategies—adequate sleep, protein-rich nutrition, and where necessary, cooling or compression—to offset the modest inflammatory response (↑ CRP). When lipolysis or taper freshness is the priority, retain conventional, unmasked HIIT. In short, employ the mask sparingly, monitor load and hydration closely, and periodise its use like any other high-stress training modality to ensure the acute physiological stress translates into meaningful performance gains. Limitations The sample comprised male amateur soccer players and a single acute exercise bout; arterial blood gases and erythropoietin were not measured. Hence, generalisation to elite, female, or longitudinal contexts is limited. Additionally, a methodological limitation of this study concerns the use of fingertip pulse oximetry for assessing oxygen saturation. Following intense exercise, peripheral vasoconstriction and movement artefacts may compromise the accuracy and reliability of SpO₂ readings. Therefore, these values should be interpreted cautiously and considered as estimative rather than definitive indicators of arterial oxygen saturation. Although the crossover design minimised between-subject variability, residual carry-over effects cannot be fully excluded despite a 72-h interval between sessions. Future directions To determine whether the acute benefits of inspiratory-resistance training translate into sustained performance improvements, future research should address three priorities: 1- Long-term comparative studies. Conduct randomised interventions of ≥ 6 weeks that pit graded mask resistances (110–130% MAS) against genuine altitude exposure. Outcomes should include VO₂max, repeated-sprint ability and erythropoietic signalling (e.g. serum EPO, reticulocyte count).2- Mechanistic insights. Track mitochondrial and capillary remodelling through muscle biopsy, electron microscopy or near-infrared spectroscopy, thereby clarifying how chronic respiratory loading affects oxygen-utilisation pathways.3- Psychophysiological viability. Assess tolerance, perceived exertion and session adherence in team-sport environments; identify whether the added respiratory strain facilitates or hinders long-term engagement and training quality. 1- Long-term comparative studies. Conduct randomised interventions of ≥ 6 weeks that pit graded mask resistances (110–130% MAS) against genuine altitude exposure. Outcomes should include VO₂max, repeated-sprint ability and erythropoietic signalling (e.g. serum EPO, reticulocyte count). 1- Long-term comparative studies. Conduct randomised interventions of ≥ 6 weeks that pit graded mask resistances (110–130% MAS) against genuine altitude exposure. Outcomes should include VO₂max, repeated-sprint ability and erythropoietic signalling (e.g. serum EPO, reticulocyte count). 2- Mechanistic insights. Track mitochondrial and capillary remodelling through muscle biopsy, electron microscopy or near-infrared spectroscopy, thereby clarifying how chronic respiratory loading affects oxygen-utilisation pathways. 2- Mechanistic insights. Track mitochondrial and capillary remodelling through muscle biopsy, electron microscopy or near-infrared spectroscopy, thereby clarifying how chronic respiratory loading affects oxygen-utilisation pathways. 3- Psychophysiological viability. Assess tolerance, perceived exertion and session adherence in team-sport environments; identify whether the added respiratory strain facilitates or hinders long-term engagement and training quality. 3- Psychophysiological viability. Assess tolerance, perceived exertion and session adherence in team-sport environments; identify whether the added respiratory strain facilitates or hinders long-term engagement and training quality. Until such evidence is available, training masks should be used sparingly and always as a supplement—never a substitute—for established conditioning methods. Carefully managed session load, hydration and recovery are essential if the acute metabolic and haematological stressors observed here are to yield meaningful, sustainable performance gains.